SOURCE: Medivation

Medivation

August 02, 2012 16:15 ET

Medivation Announces Second Quarter 2012 Financial Results Teleconference on August 9, 2012

SAN FRANCISCO, CA--(Marketwire - Aug 2, 2012) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss second quarter 2012 financial results and provide a general business update on Thursday, August 9, 2012 at 4:30 p.m. Eastern Time. A press release for the second quarter of 2012 will be released after markets close on August 9, 2012.

Interested parties may call 877-303-2523 from the U.S. or +1-253-237-1755 internationally.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contact Information

  • Contacts:
    Patrick Machado
    Chief Business & Financial Officer
    (415) 829-4101

    Anne Bowdidge
    Sr. Director, Investor Relations
    (650) 218-6900